Sanofi to buy Belgian biotech group Ablynx for 3.9bn


Shares in Belgian biotech company Ablynx surged on Monday after it agreed to be bought by French pharmaceutical group Sanofi for 45 per share in cash, or 3.9bn. Sanofi's offer trumped an offer from Novo Nordisk earlier this month of up to 30.50 a share.



from Biotech News